Bajaj Health Care Limited has got an in-principle approval letter from BSE for using its name in the Offer Document for listing its shares on the SME Platform of the BSE. For the purpose of this Offer, the Designated Stock Exchange will be the BSE Limited (“BSE”).
Company profile
Bajaj Health Care Limited started its business in 1993 with an Active Pharmaceutical Ingredients (API) manufacturing unit in Tarapur near Mumbai. The firm runs five manufacturing units for manufacture of API Intermediates and Formulations. It acquired and set up an Intermediate Unit in Tarapur MIDC, near Mumbai in November 2014. The company offers various products like APIs in the therapeutic categories of Neutraceutical (Amino Acids), Vitamins, Anti-Convulsants, Bactericidal & Bacteriostatic, Diuretic & Vasodilator, Mineral& Nutritional supplements, Bronchodilater / Anti-asthmatic and Nootropics. Formulations unit of the company makes tablets, capsules and sachets for its own brands as well as under Loan License (job work) for other pharmaceutical companies.
The company is facilitating to supply APIs and FDFs both domestically and exporting to various countries in regions like, Europe, USA, Australia, Africa, South America, etc. Glaxo Smithkline Consumer Healthcare Ltd., Ava Inc., Abbott Healthcare Pvt. Ltd., Piramal Enterprises Ltd., Pfizer Ltd., Colgate Palmolive India Ltd., Lupin Ltd. and Intas Pharmaceuticals are the main clients of the company.
The revenues of the company surged by 6.52% to Rs. 21837.63 lakhs in finacial year 2014-15 against 20,500.64 lakhs in financial year 2013-14 and 19.95% higher from Rs. 17,090.25 lakhs in Financial year 2012-2013. Net Profit after tax for 2014-15 is recorded higher at Rs. 751.48 lakhs compared to last season record Rs.197.14 lakhs and Rs. 105.85 lakhs in 2012/13.
Outlook of the Company:-
1) Experienced promoters
2) Established Marketing Setup and Diversified Customer Base
3) Wide range of products – APIs& FDFs
4) Facility designed to serve multiple products range
5) Strategic Location of Manufacturing Units
6) Compliance with Quality Standards to serve international markets
7) In-house QA / QC and R&D for quality control
Purpose of the issue:-
- Repayment of loans; and
- Funding expenditure for General Corporate Purposes.
- General corporate purpose.
Summary Of Issue:
| Issue Open:- | April 27, 2016 – May 2, 2016 |
| Issue Type | Fixed Price Issue IPO |
| Issue Size | 1,817,600 Equity Shares of Rs. 10 aggregating up to Rs 30.90 Cr |
| Face Value | Rs. 10 Per Equity Share |
| Issue Price | Rs. 170 Per Equity Share |
| Market lots | 800 Shares |
| Minimum Order Quantity | 800 Shares |
| Listing At | BSE, SME |
Promoters Of the Company
1) Mr. SajanKumar R. Bajaj:- He is a core promoter of the company. He had started his career in pharmaceutical industry in the year 1985.
2) Promoters Group (as defined by SEBI (ICDR) Regulations) :- Ms. Namrata S. Bajaj, Ms. Nihita S. Bajaj, SKR Bajaj (HUF), Mrs. Babita S. Bajaj, Bajaj Health & Nutrition Pvt. Ltd, Bansal Pharma Ltd.
Financials
| Particulars | For the year/Period ended (Rs. in Millions) | ||||
| Financial Year | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | 31-Mar-12 | 31-Mar-11 |
| Total Equity & Liabilities | 14559.28 | 14516.23 | 13074.39 | 12122.63 | 10319.87 |
| Total Assets | 14559.28 | 14516.23 | 13074.39 | 12122.63 | 10319.87 |
| Total Revenue | 21837.63 | 20500.64 | 17090.25 | 14160.78 | 12109.08 |
| Total Expenses | 20635.95 | 20171.70 | 17243.45 | 14055.65 | 11522.89 |
| Profit After Tax (PAT) | 751.48 | 197.14 | -105.58 | 65.02 | 447.30 |
Lead Manager Details:-
ARYAMAN FINANCIAL SERVICES LIMITED 60,
Khatau Building, Ground Floor,
Alkesh Dinesh Modi Marg, Fort, Mumbai – 400 001
Tel No.: +91 – 22 – 2261 8264 / 8635 Fax No.: +91 – 22 – 2263 0434
Email: info@afsl.co.in
Website: www.afsl.co.in
Contact Person: Mr. Pranav Nagar / Mr. Shreyas Shah
SEBI Registration No. INM000011344
Registrar Of The Issue:-
SHAREX DYNAMIC (I) PRIVATE LIMITED
Unit No 1, Luthra Ind. Premises, 1st Floor, 44 – E
Vasanji Marg, Andheri Kurla Road, Safed Pool, Andheri (E),Mumbai – 400 072
Tel: +91 – 22 – 2851 5606 Fax: +91 – 22 – 2851 2885
Email: shareindia@vsnl.com;
Website: www.sharexindia.com
Contact Person: Mr. K. C. Ajitkumar
SEBI Registration No.: INR000002102
Registered Office:
N- 216, MIDC, Tarapur, Boisar,
Dist. Thane – 401 506;
Tel No.: +91- 2525 – 655208 / 655209; Fax No.: +91 – 2525 – 661074
Corporate Office: 202-204, Faiz-E-Qutbi, 2nd Floor, 375, Narshi Natha Street, Mumbai – 400 009;
Tel No.: +91 – 22 – 40177477; Fax No.: +91 – 22 – 23450481
Email: investors@bajajhealth.com;
Website: www.bajajhealth.com
Contact Person: Mr. Vipul Dubey, Company Secretary and Compliance Officer.
